Chromium
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
- Chromium
Chromium: Known uses and market status in India
Summary
The TxGNN model has no candidate with a score of 0.99 or higher for Chromium, so there is currently no new predicted indication. The drug’s recorded uses are listed below; for this drug, no uses are recorded.
Quick overview
| Item | Content |
|---|---|
| New predicted indications | None (no model candidate scored 0.99 or higher) |
| Known uses recorded for this drug | 0 |
| Evidence level | Not applicable |
| India Market Status | Listed in a compiled Indian medicine price dataset (3 of 3) – CDSCO approval status is not included in this data |
| Number of Listed Products | 3 (valid: 3) |
Known uses recorded for this drug
Approved (supported by a licence or label)
| Indication | Source |
|---|---|
| none | none |
Related to an approved indication (same disease category)
| Indication | Approved category |
|---|---|
| none | none |
Relations recorded in the knowledge graph (no approval found)
| Indication |
|---|
| none |
India Market Information
| Licence | Product | Dosage form | Status |
|---|---|---|---|
| 161947 | Otski Injection | vial of 3 ml Injection | Valid |
| 219156 | Trace I.V. Injection | ampoule of 3 ml Injection | Valid |
| 35624 | Celecel Injection | vial of 3 ml Injection | Valid |
Safety Considerations
Please refer to the package insert for safety information.
Published implant literature on cobalt-chromium alloys reports metal ion release, metallosis, adverse local tissue reactions and metal hypersensitivity. That exposure is different from a chromium injection, but it is a reminder to monitor for toxicity and hypersensitivity if chromium is studied further.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.